Introduction: Leachable Screening for Parenteral Formulations is one of the most critical quality activities in modern pharmaceutical development. Because parenteral […]
Designing Leachables Screening for Parenteral Drug Products Read More »
Introduction: Error Types in E&L Data Analysis are one of the biggest hidden risks in extractables and leachables screening. Even
Error Types in E&L Screening: Omission and Misidentification Read More »
Introduction: Quantification Methods in E&L Testing play a crucial role in determining the safety of pharmaceutical products, medical devices, and
Quantifying Leachables: Relative vs Absolute Quantification Read More »
Introduction: Exaggerated vs Simulated Extraction E&L is one of the most frequently misunderstood topics in extractables and leachables studies. Many
Exaggerated vs Simulated Use Extractions: What’s the Difference? Read More »
Introduction: E&L Sample Preparation Best Practices play a crucial role in ensuring reliable results in extractables and leachables testing. Even
Best Practices for Sample Preparation in E&L Testing Read More »
INTRODUCTION The future of Extractables and Leachables (E&L) testing is being reshaped by AI, automation, and advanced CRO service models—and
Future of Extractables and Leachables (E&L) Testing: AI, Automation, and CRO Services Read More »
Introduction Extractables and Leachables (E&L) in Emerging Biologics and Advanced Therapies represent one of the most critical product-safety concerns in
Extractables and Leachables (E&L) in Emerging Biologics and Advanced Therapies Read More »
INTRODUCTION Extractables and Leachables (E&L) Requirements for U.S. Market Authorization are central to ensuring that materials contacting drug products do
INTRODUCTION Selecting a partner for Extractables and Leachables (E&L) Testing in the United States is one of the most important
INTRODUCTION Outsourcing to a U.S.-based Extractables and Leachables (E&L) testing laboratory in the United States helps pharmaceutical and biotech companies
